Comparison of Survival Outcomes in Node-Negative T1a and T1b High-risk Breast Cancer Treated with and without Adjuvant Chemotherapy

被引:0
|
作者
Carlson, K. A. [1 ]
Thompson, C. K. [1 ]
Siegel, E. L. [1 ]
Kim, S. [1 ]
Bao, J. J. [2 ]
Amersi, F. [1 ]
Giuliano, A. [1 ]
Chung, A. [1 ]
机构
[1] Cedars Sinai Med Ctr, Surg, Los Angeles, CA 90048 USA
[2] Univ Chicago, Chicago, IL 60637 USA
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
PT50
引用
收藏
页码:S98 / S98
页数:1
相关论文
共 50 条
  • [21] Incidence of axillary lymph node metastases in T1a and T1b breast carcinoma
    Elisa Rush Port
    Lee K. Tan
    Patrick I. Borgen
    Kimberly J. Van Zee
    Annals of Surgical Oncology, 1998, 5 : 23 - 27
  • [22] T1a and T1b breast cancer: A twelve-year experience
    Visser, TJ
    Haan, M
    Keidan, R
    Lucas, R
    Ingold, J
    Glover, J
    Riggo, P
    AMERICAN SURGEON, 1997, 63 (07) : 621 - 626
  • [23] Cause-specific and all-cause mortality of HER2-positive, node-negative, T1a and T1b breast cancers
    Chew, H. K.
    Brown, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [24] Prognostic value of positive human epidermal growth factor receptor 2 status and negative hormone status in patients with T1a/T1b, lymph node-negative breast cancer
    Livi, Lorenzo
    Meattini, Icro
    Saieva, Calogero
    Franzese, Ciro
    Di Cataldo, Vanessa
    Greto, Daniela
    Franceschini, Davide
    Scotti, Vieri
    Bonomo, Pierluigi
    Nori, Jacopo
    Sanchez, Luis
    Vezzosi, Vania
    Bianchi, Simonetta
    Cataliotti, Luigi
    Biti, Giampaolo
    CANCER, 2012, 118 (13) : 3236 - 3243
  • [25] Role of axillary node dissection in patients with T1a and T1b breast cancer - Mayo Clinic experience
    Mincey, BA
    Bammer, T
    Atkinson, EJ
    Perez, EA
    ARCHIVES OF SURGERY, 2001, 136 (07) : 779 - 782
  • [26] EFFICACY OF ADJUVANT CHEMOTHERAPY IN HIGH-RISK NODE-NEGATIVE BREAST-CANCER - AN INTERGROUP STUDY
    MANSOUR, EG
    GRAY, R
    SHATILA, AH
    OSBORNE, CK
    TORMEY, DC
    GILCHRIST, KW
    COOPER, MR
    FALKSON, G
    NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (08): : 485 - 490
  • [27] Adjuvant Docetaxel for High-Risk, Node-Negative Breast Cancer.
    Martin, Miguel
    Segui, Miguel A.
    Anton, Antonio
    Ruiz, Amparo
    Ramos, Manuel
    Adrover, Encarna
    Aranda, Ignacio
    Rodriguez-Lescure, Alvaro
    Grosse, Regina
    Calvo, Lourdes
    Barnadas, Agusti
    Isla, Dolores
    Martinez del Prado, Purificacion
    Ruiz Borrego, Manuel
    Zaluski, Jerzy
    Arcusa, Angels
    Munoz, Montserrat
    Lopez Vega, Jose M.
    Mel, Jose R.
    Munarriz, Blanca
    Llorca, Cristina
    Jara, Carlos
    Alba, Emilio
    Florian, Jesus
    Li, Junfang
    Lopez Garcia-Asenjo, Jose A.
    Saez, Amparo
    Jose Rios, Maria
    Almenar, Sergio
    Peiro, Gloria
    Lluch, Ana
    NEW ENGLAND JOURNAL OF MEDICINE, 2010, 363 (23): : 2200 - 2210
  • [28] EFFICACY OF ADJUVANT 9-WEEKS TRASTUZUMAB IN NODE-NEGATIVE T1A/B HER2-POSITIVE BREAST CANCER
    Sendur, M. A.
    Aksoy, S.
    Uncu, D.
    Demir, H.
    Yuksel, S.
    Ekinci, A. S.
    Kaplan, A.
    Ustaalioglu, B. B.
    Tufan, G.
    Inanc, M.
    Ozdemir, N.
    Artac, M.
    Tastekin, D.
    Kacan, T.
    Oguz, A.
    Arpaci, E.
    Yazilitas, D.
    Gumus, M.
    Zengin, N.
    Altundag, M. K.
    ANNALS OF ONCOLOGY, 2014, 25
  • [29] Favorable Prognosis in Patients with T1a,b Node-Negative Triple Negative Breast Cancers Treated with Multimodality Therapy.
    Ho, A. Y.
    Gupta, G.
    Perez, C. A.
    King, T. A.
    Pati, S. M.
    Rogers, K. H.
    Brogi, E.
    Morrow, M.
    Hudis, C.
    Traina, T.
    McCormick, B.
    Powell, S. N.
    Robson, M. E.
    CANCER RESEARCH, 2011, 71
  • [30] Chemotherapy significantly improves long-term survival of small lesion node negative metaplastic breast carcinoma in T1c population rather than T1a and T1b
    Chen, Qitong
    Zhou, Qin
    He, Hongye
    He, Yeqing
    Yuan, Yunchang
    Zou, Qiongyan
    Yi, Wenjun
    SCIENTIFIC REPORTS, 2022, 12 (01)